New treatment could halt growth of tumours in prostate cancer patients
Scientists believe a new treatment, shown to be effective in mice, could halt the growth of tumours in patients with prostate cancer.
View ArticleU of G research may lead to novel treatment approaches for late-stage ovarian...
In a potential breakthrough against ovarian cancer, University of Guelph researchers have discovered how to both shrink tumours and improve drug delivery, allowing for lower doses of chemotherapy and...
View ArticleUniversity of Leeds researchers make new synthetic anti-cancer molecule
Researchers at the University of Leeds have made a new synthetic anti-cancer molecule that targets two key mechanisms in the spread of malignant tumours through the body.
View ArticleVEGF-B can regenerate damaged peripheral nerves without causing growth of new...
Researchers at the University of Illinois at Chicago College of Medicine have found that a growth factor can regenerate damaged peripheral nerves without causing the growth of new blood vessels --...
View Article3SBio enters into exclusive license agreement with PharmAbcine for Tanibirumab
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive...
View ArticleNew combination therapy improves survival in patients with advanced ovarian...
Epithelial ovarian cancer is the most lethal cancer of the female reproductive organs, with more than 200,000 new cases and more than 125,000 deaths each year worldwide.
View ArticleResearchers reveal how cancer cells succeed at entrapping genetic program of...
Healthy cells reduce their growth when there is a lack of oxygen (hypoxia). This makes it even more surprising that hypoxia is a characteristic feature of malignant tumours. In two publications in the...
View ArticleResearchers demonstrate efficacy of Bozepinib drug against cancerogenic stem...
An Andalusian team of researchers led by the University of Granada has demonstrated the efficacy of a new drug against cancerogenic stem cells, which cause the onset and development of cancer, of...
View ArticleEylea receives Health Canada approval for treatment of CRVO and DME
Bayer Inc. announced today that it has received approval from Health Canada for Eylea (aflibercept, solution for intravitreal injection) for the treatment of diabetic macular edema (DME). This new...
View ArticleBeyondSpring Pharmaceuticals plans to initiate Plinabulin Phase 3 pivotal...
BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it plans to initiate a Phase 3 pivotal...
View ArticlePhotoacoustic imaging has potential to be used as noninvasive method to...
Cervical cancer is, in many ways, a shining example of how successful the war on cancer can be. Thanks largely to the advent of Pap smear screening, U.S. cervical cancer deaths decreased dramatically,...
View ArticleLilly receives FDA approval for CYRAMZA (ramucirumab)
Eli Lilly and Company has received its third U.S. Food and Drug Administration approval for CYRAMZA (ramucirumab).
View ArticleMirati begins dosage in MGCD265 Phase 1b clinical trial for NSCLC
Mirati Therapeutics, Inc. today announced that the first patient with Non-Small Cell Lung Cancer (NSCLC) has been dosed in a Phase 1b clinical trial of MGCD265 in selected patients exhibiting genetic...
View ArticleNovastem uses Stemedica's stem cell products to treat patient in ischemic...
Novastem, a leader in regenerative medicine, announces the treatment of its first patient in its study for ischemic stroke at Clinica Santa Clarita.
View ArticleTop cancer research and clinical developments at Dana-Farber Cancer Institute...
Immunotherapy, genomic profiling, and investigating game-changing drug therapies topped the list of most important cancer research and clinical developments at Dana-Farber Cancer Institute in 2014.
View Article3SBio, PharmAbcine sign licensing agreement to develop and market DIG-KT
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive...
View ArticleRice researchers develop new version of hydrogel to promote wound healing
Rice University scientists have found the balance necessary to aid healing with high-tech hydrogel.
View ArticleMathematical models of cancer behavior offer new insights on tumor growth
Hassan Fathallah-Shaykh, M.D., Ph.D., believes that math can transform medicine, and he has the numbers to prove it.
View ArticleBionomics initiates BNC210 Phase 1b clinical trial in healthy volunteers
Bionomics Limited has initiated a Phase 1b clinical trial in healthy volunteers of BNC210, the Company's drug candidate in development for the treatment of anxiety and depression.
View ArticleResearch describes new way of shrinking ovarian cancer tumors, improving drug...
New research published in the February 2015 issue of The FASEB Journal, may eventually help improve the five-year survival rate of ovarian cancer patients by describing a new way of shrinking ovarian...
View Article
